Analystreport

Protagonist Therapeutics (NASDAQ:PTGX) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.

Protagonist Therapeutics, Inc.  (PTGX) 
Last protagonist therapeutics, inc. earnings: 3/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.protagonist-inc.com